Suma Krishnan, 10% Owner, Director, President, Research and Development, on September 04, 2026, sold 25,000 shares in Krystal Biotech (KRYS) for $8,982,986. Following the Form 4 filing with the SEC, Krishnan has control over a total of 1,493,155 common shares of the company, with 1,302,145 shares held directly and 191,010 controlled indirectly.
SEC Filing: